Neutralizing antibodies to granulocyte–macrophage colony‐stimulating factor, interleukin‐1α and interferon‐α but not other cytokines in human immunoglobulin preparations

Human immunoglobulin preparations are used therapeutically for various disorders. Such therapy is generally safe but adverse effects occasionally occur in recipients. It has been suggested that antibodies to cytokines present in clinical immunoglobulin products may contribute to undesirable effects...

Full description

Saved in:
Bibliographic Details
Main Authors: Wadhwa, M, Meager, A, Dilger, P, Bird, C, Dolman, C, Das, R G, Thorpe, R
Format: Artigo
Language:Inglês
Published: Blackwell Science Inc 2000
Subjects:
Original Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2327128/
https://ncbi.nlm.nih.gov/pubmed/10651949
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1046/j.1365-2567.2000.00949.x
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items